Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 93 full-time employees. The firm has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code. The firm remains in possession of its assets and continues to operate its business as a debtor in possession.
Financial snapshot data is not available right now.
Loading...